NVO241115C93000
- 0.00
- 0.000.00%
Novo-Nordisk A/S Newsroom
Top Gap Ups and Downs on Friday: NVO, HSBC, AMAT and More
Large Pharmas, Biotechs Down as Industries Grapple With RFK Jr. at HHS
Eli Lilly, Novo Nordisk Shares Slide as Trump Picks RFK Jr. for HHS Post
Trending Industry Today: Viking Therapeutics Leads Losses In Weight Loss Drugs Stocks
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
Express News | Shares of Pharmaceutical Companies Are Trading Lower After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS
This Is What Whales Are Betting On Novo Nordisk
Novo Nordisk A/S (NVO) Trembled At The End Of The Quarter
Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ
Goldman Sachs Sticks to Their Buy Rating for Novo Nordisk (0QIU)
Is the weight loss drug market huge? The Lancet predicts that the overweight population in the usa will increase significantly.
A study warning predicts that the obesity crisis in the usa is expected to worsen by 2050.
Coatue Management Top Q3 Moves: Cuts Nvidia, Exits CRM & UNH, Piles Into Chinese Stocks
Novo Nordisk to Phase Out Human Insulin Pens: Report
Global Increase in Diabetes Indicates More Room for GLP-1 Meds to Grow
Top Gap Ups and Downs on Wednesday: SPOT, RIVN, STM and More
Unusual Options Activity: NVO, CSCO and Others Attract Market Bets, NVO V/OI Ratio Reaches 754.9
EU Regulators See Info From Rivals, Customers in Catalent Sale to Novo Holdings - Reuters
Hims & Hers Launches GLP-1 Drug Shortage Tracker
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
European Equities Traded in the US as American Depositary Fall in Wednesday Trading